1834 Investment Advisors’s ResMed RMD Stock Holding History

1834 Investment Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,187	Closed	-$527K	–	211
2025 Q4	$527K	Buy	2,187 +103	+5%	+$26.3K	0.07%	160
2025 Q3	$570K	Buy	+2,084	New	+$569K	0.07%	155

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

1834 Investment Advisors's RMD Position: Q1 2026 in Review

1834 Investment Advisors sold out of ResMed (RMD) in Q1 2026, closing a stake of 2,187 shares — an estimated $527K sold.

1834 Investment Advisors first reported a position in RMD in Q3 2025 and held it in 2 quarters. The position peaked at $570K in Q3 2025. 945 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

1834 Investment Advisors reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
1834 Investment Advisors sold 2,187 ResMed shares in Q1 2026, an estimated $527K.
1834 Investment Advisors first reported a position in ResMed in Q3 2025 and held it in 2 quarters.
1834 Investment Advisors's ResMed position peaked at $570K in Q3 2025.
945 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on 1834 Investment Advisors's 13F filing for Q1 2026, filed 14 May 2026.